approval
saveREBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
community read0 votes
Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 5
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalFeb 27, 2026 · 216d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalMay 16, 2024 · 868d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalAug 28, 2023 · 1130d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalApr 3, 2020 · 2372d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalNov 8, 2019 · 2519d ago
comments(0)
5-min edit window · permanent after that